Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
CACNB2 Blocking Peptide (AC1213)
Cat.#: ACPP-1213
Specifications
Despition CACNB2 Blocking Peptide for Immmunodepletion, Competition Assay SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1389 AHSG (AC1389) 10 µg inquiry ACPP-1210 Alpha SNAP Blocking Peptide (AC1210) 250 µg inquiry ACPP-1820 Rat CNTF Protein, His (AC1820) 2 µg inquiry ACPP-1706 Human HPCAL1 Protein (AC1706) 2 µg inquiry ACPP-1025 Recombinant Human GPR56 Protein (6×His Tag) (AC1025) 50 µg inquiry ACPP-1744 Human C1q Protein (AC1744) 200 µg inquiry ACPP-1003 Recombinant Human NOTCH3 Protein (Fc Tag) (AC1003) 50 µg inquiry ACPP-1442 Human TBCB Protein (AC1442) 5 µg inquiry ACPP-1168 KCNJ5 Blocking Peptide (AC1168) 250 µg inquiry ACPP-1243 ELOVL4 Blocking Peptide (AC1243) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket